[Anticoagulant therapy of hemostatic disorders in suppurative septic diseases in children]

Area of Science:

• Pediatric Hematology
• Infectious Diseases
• Critical Care Medicine

Background:

• Pyoseptic diseases in children can lead to a disturbed hemostasis system.
• Disseminated intravascular blood coagulation (DIC) is a serious complication in pediatric sepsis.
• Effective management of coagulopathy in critically ill children is crucial.

Purpose of the Study:

• To evaluate the efficacy of anticoagulative therapy in children with pyoseptic diseases and DIC.
• To determine the optimal level of anticoagulation for pediatric patients with DIC.
• To assess the impact of individualized heparin dosing on clinical outcomes.

Main Methods:

• Retrospective analysis of 50 pediatric patients treated for pyoseptic diseases and DIC.
• Implementation of controlled hypocoagulation as the therapeutic strategy.
• Individualized daily dosing of heparin based on patient-specific parameters.

Main Results:

• Controlled hypocoagulation demonstrated a beneficial effect in managing DIC in pediatric patients.
• Individualized heparin dosage was associated with a pronounced positive clinical response.
• The therapeutic approach led to improved hemostasis control in the studied cohort.

Conclusions:

• Anticoagulative therapy for pediatric DIC should be managed as controlled hypocoagulation.
• Tailored heparin dosing is essential for achieving significant clinical improvement.
• This therapeutic strategy offers a promising approach for managing coagulopathy in pediatric pyoseptic diseases.